Search
Thursday, 10 February 2022 (3 p.m. - 4 p.m. JST)
In 2021 we saw an increasing number of carve out transactions as businesses spun off non-core or non-performing businesses or sold businesses to obtain capital for other activities. These...
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
12 September 2019
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
